Global Lipidic Cubic Phase Crystallization Service 麻豆原创 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR042511837

Publication Date:

April 28, 2025

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Lipidic Cubic Phase Crystallization Service market size was valued at US$ 330 million in 2024 and is forecast to a readjusted size of USD 502 million by 2031 with a CAGR of 6.2% during review period.
Lipidic Cubic Phase (LCP) has become a popular technique for membrane protein crystallization. It has been particularly useful in the field of G-protein Coupled Receptor Protein research, leading to numerous structure solutions. It is the result of mixing aqueous and surfactant components to form a lattice of quasi-lipid phase and aqueous channels that can support membrane protein crystal growth.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents鈥� wealth and the improvement of health awareness will drive the demand for medicines.
This report is a detailed and comprehensive analysis for global Lipidic Cubic Phase Crystallization Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Lipidic Cubic Phase Crystallization Service market size and forecasts, in consumption value ($ Million), 2020-2031
Global Lipidic Cubic Phase Crystallization Service market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Lipidic Cubic Phase Crystallization Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Lipidic Cubic Phase Crystallization Service market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lipidic Cubic Phase Crystallization Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lipidic Cubic Phase Crystallization Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cube Biotech, Creative Biostructure, Formulatrix, Anatrace, Jena Bioscience GmbH, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Lipidic Cubic Phase Crystallization Service market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Monoolein
Monopalmitolein
Others
麻豆原创 segment by Application
Pharmaceutical Companies
Academic Research Institutes
Others
麻豆原创 segment by players, this report covers
Cube Biotech
Creative Biostructure
Formulatrix
Anatrace
Jena Bioscience GmbH
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Lipidic Cubic Phase Crystallization Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Lipidic Cubic Phase Crystallization Service, with revenue, gross margin, and global market share of Lipidic Cubic Phase Crystallization Service from 2020 to 2025.
Chapter 3, the Lipidic Cubic Phase Crystallization Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Lipidic Cubic Phase Crystallization Service market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Lipidic Cubic Phase Crystallization Service.
Chapter 13, to describe Lipidic Cubic Phase Crystallization Service research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Lipidic Cubic Phase Crystallization Service by Type
1.3.1 Overview: Global Lipidic Cubic Phase Crystallization Service 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Lipidic Cubic Phase Crystallization Service Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Monoolein
1.3.4 Monopalmitolein
1.3.5 Others
1.4 Global Lipidic Cubic Phase Crystallization Service 麻豆原创 by Application
1.4.1 Overview: Global Lipidic Cubic Phase Crystallization Service 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Pharmaceutical Companies
1.4.3 Academic Research Institutes
1.4.4 Others
1.5 Global Lipidic Cubic Phase Crystallization Service 麻豆原创 Size & Forecast
1.6 Global Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Forecast by Region
1.6.1 Global Lipidic Cubic Phase Crystallization Service 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Lipidic Cubic Phase Crystallization Service 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Cube Biotech
2.1.1 Cube Biotech Details
2.1.2 Cube Biotech Major Business
2.1.3 Cube Biotech Lipidic Cubic Phase Crystallization Service Product and Solutions
2.1.4 Cube Biotech Lipidic Cubic Phase Crystallization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Cube Biotech Recent Developments and Future Plans
2.2 Creative Biostructure
2.2.1 Creative Biostructure Details
2.2.2 Creative Biostructure Major Business
2.2.3 Creative Biostructure Lipidic Cubic Phase Crystallization Service Product and Solutions
2.2.4 Creative Biostructure Lipidic Cubic Phase Crystallization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Creative Biostructure Recent Developments and Future Plans
2.3 Formulatrix
2.3.1 Formulatrix Details
2.3.2 Formulatrix Major Business
2.3.3 Formulatrix Lipidic Cubic Phase Crystallization Service Product and Solutions
2.3.4 Formulatrix Lipidic Cubic Phase Crystallization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Formulatrix Recent Developments and Future Plans
2.4 Anatrace
2.4.1 Anatrace Details
2.4.2 Anatrace Major Business
2.4.3 Anatrace Lipidic Cubic Phase Crystallization Service Product and Solutions
2.4.4 Anatrace Lipidic Cubic Phase Crystallization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Anatrace Recent Developments and Future Plans
2.5 Jena Bioscience GmbH
2.5.1 Jena Bioscience GmbH Details
2.5.2 Jena Bioscience GmbH Major Business
2.5.3 Jena Bioscience GmbH Lipidic Cubic Phase Crystallization Service Product and Solutions
2.5.4 Jena Bioscience GmbH Lipidic Cubic Phase Crystallization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Jena Bioscience GmbH Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Lipidic Cubic Phase Crystallization Service Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Lipidic Cubic Phase Crystallization Service by Company Revenue
3.2.2 Top 3 Lipidic Cubic Phase Crystallization Service Players 麻豆原创 Share in 2024
3.2.3 Top 6 Lipidic Cubic Phase Crystallization Service Players 麻豆原创 Share in 2024
3.3 Lipidic Cubic Phase Crystallization Service 麻豆原创: Overall Company Footprint Analysis
3.3.1 Lipidic Cubic Phase Crystallization Service 麻豆原创: Region Footprint
3.3.2 Lipidic Cubic Phase Crystallization Service 麻豆原创: Company Product Type Footprint
3.3.3 Lipidic Cubic Phase Crystallization Service 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Lipidic Cubic Phase Crystallization Service Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Lipidic Cubic Phase Crystallization Service 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Lipidic Cubic Phase Crystallization Service Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Lipidic Cubic Phase Crystallization Service 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Lipidic Cubic Phase Crystallization Service Consumption Value by Type (2020-2031)
6.2 North America Lipidic Cubic Phase Crystallization Service 麻豆原创 Size by Application (2020-2031)
6.3 North America Lipidic Cubic Phase Crystallization Service 麻豆原创 Size by Country
6.3.1 North America Lipidic Cubic Phase Crystallization Service Consumption Value by Country (2020-2031)
6.3.2 United States Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Lipidic Cubic Phase Crystallization Service Consumption Value by Type (2020-2031)
7.2 Europe Lipidic Cubic Phase Crystallization Service Consumption Value by Application (2020-2031)
7.3 Europe Lipidic Cubic Phase Crystallization Service 麻豆原创 Size by Country
7.3.1 Europe Lipidic Cubic Phase Crystallization Service Consumption Value by Country (2020-2031)
7.3.2 Germany Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Lipidic Cubic Phase Crystallization Service Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Lipidic Cubic Phase Crystallization Service Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Lipidic Cubic Phase Crystallization Service 麻豆原创 Size by Region
8.3.1 Asia-Pacific Lipidic Cubic Phase Crystallization Service Consumption Value by Region (2020-2031)
8.3.2 China Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Lipidic Cubic Phase Crystallization Service Consumption Value by Type (2020-2031)
9.2 South America Lipidic Cubic Phase Crystallization Service Consumption Value by Application (2020-2031)
9.3 South America Lipidic Cubic Phase Crystallization Service 麻豆原创 Size by Country
9.3.1 South America Lipidic Cubic Phase Crystallization Service Consumption Value by Country (2020-2031)
9.3.2 Brazil Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Lipidic Cubic Phase Crystallization Service Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Lipidic Cubic Phase Crystallization Service Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Lipidic Cubic Phase Crystallization Service 麻豆原创 Size by Country
10.3.1 Middle East & Africa Lipidic Cubic Phase Crystallization Service Consumption Value by Country (2020-2031)
10.3.2 Turkey Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Lipidic Cubic Phase Crystallization Service 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Lipidic Cubic Phase Crystallization Service 麻豆原创 Drivers
11.2 Lipidic Cubic Phase Crystallization Service 麻豆原创 Restraints
11.3 Lipidic Cubic Phase Crystallization Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Lipidic Cubic Phase Crystallization Service Industry Chain
12.2 Lipidic Cubic Phase Crystallization Service Upstream Analysis
12.3 Lipidic Cubic Phase Crystallization Service Midstream Analysis
12.4 Lipidic Cubic Phase Crystallization Service Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Cube Biotech
Creative Biostructure
Formulatrix
Anatrace
Jena Bioscience GmbH

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.